Roche Bobois S.A. engages in the furniture design and distribution business in France, Japan, and internationally. The company offers living room products, such as sofas and sofa beds, cocktail tables, TV units, armchairs, bookcases, cabinets, consoles, and occasional furniture; dining room products, including chairs, stools, benches, dining tables, and dining room storage products; dining room products that include chairs, stools, benches, dining tables, and dining room storage products; bedroom products comprising beds, wardrobes, and other bedroom furniture products; outdoor furniture products, including sofas, armchair, and decoration; desks and office chairs; and other products, including lights, cushions, rugs, mirrors, and home furnishings, as well as other furniture products. It offers its products under the Roche Bobois and Cuir Center brand names. The company was formerly known as Furn-Invest S.A.S. Roche Bobois S.A. was founded in 1960 and is headquartered in Paris, France.…
Roche Bobois S A : DeclarationDirigeants
Roche Bobois (EPA: RBO) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Furnishings, Fixtures & Appliances industry, part of the Consumer Cyclical sector, and reports about 1,074 employees.
The shares were at 16.85 EUR on 20 November 2026, down 51.9% over 52 weeks. Its 52-week range is 12.45 EUR to 37.60 EUR: the price is 55.2% below the high and 35.3% above the low.
At a market capitalisation of 169.25M EUR, it trades at 22.8 times trailing earnings and 18.2 times forward earnings. The median trailing P/E of its 15 largest Furnishings, Fixtures & Appliances peers is 19.3, a premium of 18% for RBO. It pays a dividend yielding 4.75% (it pays out 108% of its earnings), against a median of 3.00% among the dividend payers in that peer group.
Roche Bobois reports return on equity of 11.0%, an operating margin of 4.4% and revenue down 8.9% year over year.
Its debt exceeds its cash by 152.30M EUR, a debt-to-equity ratio of 2.20. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 20.83 EUR is 23.6% above the current price.
No upcoming events tracked.